StemTek Therapeutics company

StemTek is a biopharmaceutical company focused on the research and development of drugs for cancer treatment. It utilizes stem cell centric point-of-view technologies for cancer therapy. It allows users to profile their pipeline of compounds for their effect on cancer stem cell populations, using 3D culture models. The company was founded in Angel Martin and Olatz Esnaola and is based in Bilbao, Spain.
Technology: Regenerative Medicine
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Bilbao, Pais Vasco, Spain
Founded Date: 2013-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Total Funding: €50K
Estimated Revenue: Less than $1M
Last Funding Type: Seed

Visit Website
Register and Claim Ownership